HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,477-1,488 of 1,979
Drug study icon
CompletedNCT00140179

Valnoctamide in Mania

Official study title

Valnoctamide as a Valproate Substitute With Low Teratogenic Potential: Double-Blind Controlled Clinical Trial

This study has finished and is no longer accepting participants.

Multiple locations, including Afula
Bipolarity, SchizophreniaMedication studyAges 18–60
Countries
Israel
Sponsor
Beersheva Mental Health Center
Drug study icon
CompletedNCT00813800

Varenicline in Bipolar Depressed Patients

Official study title

Varenicline for Smoking Cessation in Bipolar Depressed Patients: An Open-Label 12-week Feasibility Trial

This study has finished and is no longer accepting participants.

In Rochester
Bipolarity, DepressionMedication studyAges 18–65
Countries
United States
Sponsor
Mark Frye
Drug study icon
CompletedNCT01431573

Wake Therapy in the Treatment of Depression

Official study title

Combined Wake Therapy, Light Therapy, and Lithium for Bipolar and Refractory Depression

This study has finished and is no longer accepting participants.

In New York
Depression, BipolarityMedication studyAges 18–75
Countries
United States
Sponsor
New York State Psychiatric Institute
Drug study icon
Recruitment unclearEUCTR 2021-001337-40

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO DETERMINE EFFICACY AND SAFETY OF BXCL501 IN AGITATION ASSOCIATED WITH PEDIATRIC SCHIZOPHRENIA AND Bipolarity

Official study title

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO DETERMINE EFFICACY AND SAFETY OF BXCL501 IN AGITATION ASSOCIATED WITH PEDIATRIC SCHIZOPHRENIA AND BIPOLAR DISORDER

Original registry wording; source language not specified.

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Spain
Schizophrenia, BipolarityHistorical research record
Countries
Spain
Sponsor
BioXcel Therapeutics, Inc.
Drug study icon
CompletedNCT03543410

A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression

What is this study about?

Researchers compared SEP-4199 200 mg, SEP-4199 400 mg and placebo to find out how the approaches affected depression symptoms in people with bipolarity type I during a depressive episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Cerritos
Depression, BipolarityMedication studyAges 18–65
Countries
United States, Bulgaria, Japan, + 5 others
Sponsor
Sumitomo Pharma America, Inc.
Drug study icon
CompletedNCT00641927

Antidepressant Therapy for Bipolar II Major Depression

What is this study about?

Researchers compared Venlafaxine and Lithium Carbonate to find out how the approaches affected depression symptoms in people with bipolarity type II during a depressive episode.

This study has finished and is no longer accepting participants.

In Philadelphia
Bipolarity, DepressionMedication studyAges 18+
Countries
United States
Sponsor
Stanley Medical Research Institute
Behavioral study icon
CompletedNCT01729650

Effectiveness of a Physical Activity and Diet Program in people with Psychotic Disorder (CapiCor)

Official study title

Effectiveness of a Physical Activity and Diet Program, Coordinated Between Primary Care and Mental Health, to Modify Cardiovascular Risk Factors in Patients With Schizophrenia or Bipolar Disorder (CapiCor)

This study has finished and is no longer accepting participants.

In Barcelona
Schizophrenia, BipolarityBehavioural studyAges 18–65
Countries
Spain
Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Behavioral study icon
CompletedACTRN12608000472370

'Songs for Life': Group music therapy for serious and enduring mental illness (SEMI) - a control study

Official study title

Evaluation of a group music therapy program on quality of life in people living with severe and enduring mental illness (SEMI) in the community

This study has finished and is no longer accepting participants.

Multiple locations, including Fitzroy
Schizophrenia, Bipolarity, ...Interventional studyAges 18+
Countries
Australia
Sponsor
The University of Melbourne
Drug study icon
CompletedACTRN12618000966291

A placebo and comparator controlled phase 1, safety and tolerability study of 3 ascending doses of INP105 (intranasal OLZ by I231 POD® device).

Official study title

A Phase 1, Randomized, Double-Blind, Placebo- and Active-Controlled, Single-Ascending-Dose, 2-Way, Incomplete Block, 2-Period Crossover, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of 3 Doses of INP105 (olanzapine delivered by I231 POD® Device) Nasal Spray in Healthy Volunteers

This study has finished and is no longer accepting participants.

In Melbourne
Schizophrenia, BipolarityInterventional studyAges 18–55
Countries
Australia
Sponsor
Clinical Network Services (CNS) Pty Ltd
Behavioral study icon
CompletedACTRN12616000866404

A control study of Social Skills Training (SCIT) in those diagnosed with psychosis.

Official study title

A randomised control trial on the effect of Social Cognition Interaction Training (SCIT) on social functioning in those diagnosed with psychosis.

This study has finished and is no longer accepting participants.

In Australia
Schizophrenia, BipolarityInterventional studyAges 18–65
Countries
Australia
Sponsor
The University of Queensland
Other study type icon
CompletedACTRN12620000577910

Bridging the Gap between Physical and Mental Illness in Community Pharmacy (PharMIbridge): Controlled study

Official study title

A cluster randomised controlled trial of a pharmacist-led intervention for people living with severe and persistent mental illness to support medication adherence, physical health and psychological wellbeing

This study has finished and is no longer accepting participants.

In Australia
Schizophrenia, Bipolarity, ...Interventional studyAges 16+
Countries
Australia
Sponsor
The Pharmacy Guild of Australia

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.